The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.
about
Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience.MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study.
P2860
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The Role of Regional Therapies ...... of Improved Systemic Options.
@ast
The Role of Regional Therapies ...... of Improved Systemic Options.
@en
type
label
The Role of Regional Therapies ...... of Improved Systemic Options.
@ast
The Role of Regional Therapies ...... of Improved Systemic Options.
@en
prefLabel
The Role of Regional Therapies ...... of Improved Systemic Options.
@ast
The Role of Regional Therapies ...... of Improved Systemic Options.
@en
P2860
P356
P1433
P1476
The Role of Regional Therapies ...... of Improved Systemic Options.
@en
P2093
Emmanuel Gabriel
Joseph Skitzki
P2860
P304
P356
10.3390/CANCERS7030830
P577
2015-07-01T00:00:00Z